Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2566 to 2580 of 7685 results

  1. Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux disease

    In development [GID-IPG10345] Expected publication date: 17 April 2025

    Interventional procedures guidance
    In development

  2. Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer ID6346

    In development [GID-TA11405] Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphomas after first-line chemotherapy when a stem cell transplant is suitable [ID3887]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 5 December 2024.

    Technology appraisal guidance
    In consultation

  4. Abortion Care

    In development [GID-NG10433] Expected publication date: TBC

    NICE guideline
    In development

  5. Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux disease: interventional procedure consultation

    We are listening to your views on this Interventional procedures guidance. Comments close 12 December 2024.

    Interventional procedures guidance
    In consultation

  6. Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphomas after first-line chemotherapy when a stem cell transplant is suitable [ID3887]

    In development [GID-TA10778] Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen ID6462

    In development [GID-TA11602] Expected publication date: 11 September 2025

    Technology appraisal guidance
    In development

  8. Digital technologies to support self-management of COPD: early value assessment

    In development [GID-HTE10030] Expected publication date: 19 December 2024

    Health technology evaluations
    In development

  9. Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment: draft guidance

    We are listening to your views on this Health technology evaluation. Comments close 17 December 2024.

    Health technology evaluation
    In consultation

  10. Non-alcoholic fatty liver disease (NAFLD): assessment and management

    In development [GID-NG10434] Expected publication date: TBC

    NICE guideline
    In development

  11. Intrapartum Care - maternal hyponatremia

    In development [GID-NG10431] Expected publication date: 26 March 2025

    NICE guideline
    In development

  12. Tirzepatide for managing overweight and obesity [ID6179]

    In development [GID-TA11156] Expected publication date: 14 January 2025

    Technology appraisal guidance
    In development

  13. Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) (DG60)

    Evidence-based recommendations on digital technologies for assessing attention deficit hyperactivity disorder (ADHD)

    Diagnostics guidance
    Published
    21 October 2024
    View recommendations

    Sections for DG60

  14. Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (DG61)

    Evidence-based recommendations on CorVue (Abbott Medical), HeartInsight (Biotronik), HeartLogic (Boston Scientific) and TriageHF (Medtronic) for algorithm-based remote monitoring in people with cardiac implantable electronic devices

    Diagnostics guidance
    Published
    24 October 2024
    View recommendations

    Sections for DG61

  15. Erdafitinib for treating metastatic or unresectable FGFR-altered urothelial cancer [ID1333]

    In development [GID-TA10252] Expected publication date: 26 February 2025

    Technology appraisal guidance
    In development